What is the difference between POSACONAZOLE and TERBINAFINE HYDROCHLORIDE?

POSACONAZOLE and TERBINAFINE HYDROCHLORIDE are both Antifungals, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can POSACONAZOLE and TERBINAFINE HYDROCHLORIDE be used for the same conditions?

Both medications are prescribed for overlapping indications including See full prescribing information. Always verify with your prescriber and the current FDA label before switching.

Is posaconazole the same as Terbinafine?

No. posaconazole (POSACONAZOLE) and Terbinafine (TERBINAFINE HYDROCHLORIDE) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, POSACONAZOLE or TERBINAFINE HYDROCHLORIDE?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from POSACONAZOLE to TERBINAFINE HYDROCHLORIDE?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

POSACONAZOLE vs TERBINAFINE HYDROCHLORIDE

Compare POSACONAZOLE (posaconazole) and TERBINAFINE HYDROCHLORIDE (Terbinafine) — clinical data, side effects, and patient experiences.

POSACONAZOLE

posaconazole · Antifungal

How it works

12.1 Mechanism of Action Posaconazole is an azole antifungal agent [ see Clinical Pharmacology (12.4) ].

Approved for

See full prescribing information

OralTablet

TERBINAFINE HYDROCHLORIDE

Terbinafine · Antifungal

How it works

12.1 Mechanism of Action Terbinafine is an allylamine antifungal [see ] .

Approved for

1 INDICATIONS AND USAGE Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment

appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation

fungal culture

OralTablet

Quick Comparison

POSACONAZOLETERBINAFINE HYDROCHLORIDE

Drug Class

Antifungal

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

POSACONAZOLE

Drug Not Working

>10%

Fever

1-10%

Diarrhea

0.1-1%

Nausea

0.1-1%

Condition Worsened

0.1-1%

TERBINAFINE HYDROCHLORIDE

Drug Not Working

>10%

Rash

1-10%

Itching

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

0.1-1%

FDA Warnings

POSACONAZOLE

5 WARNINGS AND PRECAUTIONS Calcineurin-Inhibitor Toxicity : Posaconazole increases concentrations of cyclosporine or tacrolimus; reduce dose of cyclosporine and tacrolimus and monitor concentrations frequently
5 ) Vincristine Toxicity : Concomitant administration of azole antifungals, including posaconazole, with vincristine has been associated with neurotoxicity and other serious adverse reactions; reserve azole antifungals, including posaconazole, for patients receiving a vinca alkaloid, including vincristine, who have no alternative antifungal treatment options
10 ) Venetoclax Toxicity : Concomitant administration of posaconazole with venetoclax may increase venetoclax toxicities, including the risk of tumor lysis syndrome, neutropenia, and serious infections; monitor for toxicity and reduce venetoclax dose
Nephrotoxicity and leukoencephalopathy (including deaths) have been reported in clinical efficacy studies in patients with elevated cyclosporine or tacrolimus concentrations

TERBINAFINE HYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS • Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine
1 Hepatotoxicity Terbinafine tablets are contraindicated for patients with chronic or active liver disease
Cases of liver failure, some leading to liver transplant or death, have occurred with the use of terbinafine tablets in individuals with and without preexisting liver disease
In the majority of liver cases reported in association with use of terbinafine tablets, the patients had serious underlying systemic conditions

Clinical Trial Data

No head-to-head clinical studies found for POSACONAZOLE vs TERBINAFINE HYDROCHLORIDE.

POSACONAZOLE vs TERBINAFINE HYDROCHLORIDE: What You Should Know

Key Differences

Both POSACONAZOLE and TERBINAFINE HYDROCHLORIDE belong to the Antifungal class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

POSACONAZOLE carries 4 FDA warnings. TERBINAFINE HYDROCHLORIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

KETOCONAZOLE vs TERBINAFINE HYDROCHLORIDE→NYSTATIN vs TERBINAFINE HYDROCHLORIDE→METRONIDAZOLE vs TERBINAFINE HYDROCHLORIDE→CLOTRIMAZOLE TOPICAL vs TERBINAFINE HYDROCHLORIDE→AMPHOTERICIN B vs TERBINAFINE HYDROCHLORIDE→TAVABOROLE TOPICAL SOLUTION vs TERBINAFINE HYDROCHLORIDE→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

POSACONAZOLE: DailyMed label · FAERS adverse events · ClinicalTrials.gov
TERBINAFINE HYDROCHLORIDE: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

POSACONAZOLE vs TERBINAFINE HYDROCHLORIDE

Compare POSACONAZOLE (posaconazole) and TERBINAFINE HYDROCHLORIDE (Terbinafine) — clinical data, side effects, and patient experiences.

POSACONAZOLE

posaconazole · Antifungal

How it works

12.1 Mechanism of Action Posaconazole is an azole antifungal agent [ see Clinical Pharmacology (12.4) ].

Approved for

See full prescribing information

OralTablet

TERBINAFINE HYDROCHLORIDE

Terbinafine · Antifungal

How it works

12.1 Mechanism of Action Terbinafine is an allylamine antifungal [see ] .

Approved for

1 INDICATIONS AND USAGE Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium). Prior to initiating treatment

appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation

fungal culture

OralTablet

Quick Comparison

POSACONAZOLETERBINAFINE HYDROCHLORIDE

Drug Class

Antifungal

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

POSACONAZOLE

Drug Not Working

>10%

Fever

1-10%

Diarrhea

0.1-1%

Nausea

0.1-1%

Condition Worsened

0.1-1%

TERBINAFINE HYDROCHLORIDE

Drug Not Working

>10%

Rash

1-10%

Itching

1-10%

Fatigue

1-10%

Nausea

1-10%

Headache

1-10%

Diarrhea

1-10%

Shortness of Breath

0.1-1%

FDA Warnings

POSACONAZOLE

5 WARNINGS AND PRECAUTIONS Calcineurin-Inhibitor Toxicity : Posaconazole increases concentrations of cyclosporine or tacrolimus; reduce dose of cyclosporine and tacrolimus and monitor concentrations frequently
5 ) Vincristine Toxicity : Concomitant administration of azole antifungals, including posaconazole, with vincristine has been associated with neurotoxicity and other serious adverse reactions; reserve azole antifungals, including posaconazole, for patients receiving a vinca alkaloid, including vincristine, who have no alternative antifungal treatment options
10 ) Venetoclax Toxicity : Concomitant administration of posaconazole with venetoclax may increase venetoclax toxicities, including the risk of tumor lysis syndrome, neutropenia, and serious infections; monitor for toxicity and reduce venetoclax dose
Nephrotoxicity and leukoencephalopathy (including deaths) have been reported in clinical efficacy studies in patients with elevated cyclosporine or tacrolimus concentrations

TERBINAFINE HYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS • Liver failure, sometimes leading to liver transplant or death, has occurred with the use of oral terbinafine
1 Hepatotoxicity Terbinafine tablets are contraindicated for patients with chronic or active liver disease
Cases of liver failure, some leading to liver transplant or death, have occurred with the use of terbinafine tablets in individuals with and without preexisting liver disease
In the majority of liver cases reported in association with use of terbinafine tablets, the patients had serious underlying systemic conditions

Clinical Trial Data

No head-to-head clinical studies found for POSACONAZOLE vs TERBINAFINE HYDROCHLORIDE.

POSACONAZOLE vs TERBINAFINE HYDROCHLORIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.